載入...
Efficacy of Lusutrombopag for Thrombocytopenia in Patients with Chronic Liver Disease Scheduled to Undergo Invasive Procedures
OBJECTIVE: Lusutrombopag is a thrombopoietin receptor agonist that improves thrombocytopenia in patients with chronic liver disease scheduled to undergo invasive procedures. However, information on the efficacy of repeated lusutrombopag treatment and factors associated with the treatment is scarce....
Na minha lista:
| 發表在: | Intern Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
The Japanese Society of Internal Medicine
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8024946/ https://ncbi.nlm.nih.gov/pubmed/33087674 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.5930-20 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|